IS8074A - Setin 1,4- Díazepín og notkun theirra - Google Patents

Setin 1,4- Díazepín og notkun theirra

Info

Publication number
IS8074A
IS8074A IS8074A IS8074A IS8074A IS 8074 A IS8074 A IS 8074A IS 8074 A IS8074 A IS 8074A IS 8074 A IS8074 A IS 8074A IS 8074 A IS8074 A IS 8074A
Authority
IS
Iceland
Prior art keywords
diazepines
substituted
Prior art date
Application number
IS8074A
Other languages
English (en)
Inventor
Lu Tianbao
L. Milkiewicz Karen
Leonard Kristi
Raboisson Pierre
David Cummings Maxwell
R. Calvo Raul
J. Parks Daniel
V. Louis
Jose Marugan Sanchez Juan
Gushue Joan
Original Assignee
3-Dimensional Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3-Dimensional Pharmaceuticals, Inc. filed Critical 3-Dimensional Pharmaceuticals, Inc.
Publication of IS8074A publication Critical patent/IS8074A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L45/00—Routing or path finding of packets in data switching networks
    • H04L45/02—Topology update or discovery
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L45/00—Routing or path finding of packets in data switching networks
    • H04L45/24—Multipath
    • H04L45/245—Link aggregation, e.g. trunking
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L45/00—Routing or path finding of packets in data switching networks
    • H04L45/50—Routing or path finding of packets in data switching networks using label swapping, e.g. multi-protocol label switch [MPLS]
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L47/00—Traffic control in data switching networks
    • H04L47/50—Queue scheduling
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02D—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN INFORMATION AND COMMUNICATION TECHNOLOGIES [ICT], I.E. INFORMATION AND COMMUNICATION TECHNOLOGIES AIMING AT THE REDUCTION OF THEIR OWN ENERGY USE
    • Y02D30/00—Reducing energy consumption in communication networks
    • Y02D30/50—Reducing energy consumption in communication networks in wire-line communication networks, e.g. low power modes or reduced link rate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Data Exchanges In Wide-Area Networks (AREA)
IS8074A 2003-04-25 2005-10-14 Setin 1,4- Díazepín og notkun theirra IS8074A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46526503P 2003-04-25 2003-04-25
PCT/US2004/012240 WO2004096134A2 (en) 2003-04-25 2004-04-21 Substituted 1,4-diazepines and uses thereof

Publications (1)

Publication Number Publication Date
IS8074A true IS8074A (is) 2005-10-14

Family

ID=33418213

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8074A IS8074A (is) 2003-04-25 2005-10-14 Setin 1,4- Díazepín og notkun theirra

Country Status (14)

Country Link
US (1) US20040213264A1 (is)
EP (1) EP1617807A4 (is)
JP (1) JP2007525457A (is)
KR (1) KR20060007035A (is)
CN (1) CN1809362A (is)
AU (1) AU2004233833A1 (is)
BR (1) BRPI0409641A (is)
CA (1) CA2523561A1 (is)
CO (1) CO5700770A2 (is)
HR (1) HRP20050919A2 (is)
IS (1) IS8074A (is)
MX (1) MXPA05011411A (is)
NO (1) NO20055568L (is)
WO (1) WO2004096134A2 (is)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050227932A1 (en) * 2002-11-13 2005-10-13 Tianbao Lu Combinational therapy involving a small molecule inhibitor of the MDM2: p53 interaction
US7085574B2 (en) * 2003-04-15 2006-08-01 Qualcomm, Incorporated Grant channel assignment
US7386630B2 (en) * 2003-04-30 2008-06-10 Nokia Corporation Using policy-based management to support Diffserv over MPLS network
AT501480B8 (de) * 2004-09-15 2007-02-15 Tttech Computertechnik Ag Verfahren zum erstellen von kommunikationsplänen für ein verteiltes echtzeit-computersystem
CN100334857C (zh) * 2004-09-27 2007-08-29 华为技术有限公司 一种环网及其业务实现方法
US7453804B1 (en) * 2005-02-08 2008-11-18 Packeteer, Inc. Aggregate network resource utilization control scheme
US20060187828A1 (en) * 2005-02-18 2006-08-24 Broadcom Corporation Packet identifier for use in a network device
US7936770B1 (en) * 2005-03-08 2011-05-03 Enterasys Networks, Inc. Method and apparatus of virtual class of service and logical queue representation through network traffic distribution over multiple port interfaces
US9608929B2 (en) * 2005-03-22 2017-03-28 Live Nation Entertainment, Inc. System and method for dynamic queue management using queue protocols
US7889711B1 (en) 2005-07-29 2011-02-15 Juniper Networks, Inc. Filtering traffic based on associated forwarding equivalence classes
TW201402124A (zh) 2005-08-19 2014-01-16 Array Biopharma Inc 作為類鐸受體（ｔｏｌｌ-ｌｉｋｅ ｒｅｃｅｐｔｏｒ）調節劑之８-經取代苯并氮雜呯
TWI382019B (zh) 2005-08-19 2013-01-11 Array Biopharma Inc 作為類鐸受體（ｔｏｌｌ-ｌｉｋｅ ｒｅｃｅｐｔｏｒ）調節劑之胺基二氮雜呯
JP2009542664A (ja) * 2006-06-30 2009-12-03 シェーリング コーポレイション Ｐ５３活性を増大させる置換されたピペリジンの使用の方法
AU2007332493A1 (en) 2006-12-14 2008-06-19 Daiichi Sankyo Company, Limited Imidazothiazole derivatives
JP4878391B2 (ja) * 2006-12-18 2012-02-15 テレフオンアクチーボラゲット エル エム エリクソン（パブル） 適応的なキュー待ち時間を伴うスケジューリング及びキューマネージメント
WO2009151069A1 (ja) 2008-06-12 2009-12-17 第一三共株式会社 ４，７－ジアザスピロ［２．５］オクタン環構造を有するイミダゾチアゾール誘導体
US7948986B1 (en) 2009-02-02 2011-05-24 Juniper Networks, Inc. Applying services within MPLS networks
RU2016108987A (ru) 2009-08-18 2018-11-26 Вентиркс Фармасьютикалз, Инк. Замещенные бензоазепины в качестве модуляторов toll-подобного рецептора
CN105669553A (zh) 2009-08-18 2016-06-15 文蒂雷克斯药品公司 作为toll样受体调节剂的取代的苯并氮杂*
CU24130B1 (es) 2009-12-22 2015-09-29 Novartis Ag Isoquinolinonas y quinazolinonas sustituidas
US8440693B2 (en) 2009-12-22 2013-05-14 Novartis Ag Substituted isoquinolinones and quinazolinones
US8775352B2 (en) * 2010-03-01 2014-07-08 At&T Intellectual Property I, L.P. Methods and apparatus to model end-to-end class of service policies in networks
CN102190631B (zh) * 2010-03-10 2014-10-29 中国人民解放军63975部队 苯二氮卓化合物的制备方法
EP2855483B1 (en) 2012-05-24 2017-10-25 Novartis AG Pyrrolopyrrolidinone compounds
WO2014115077A1 (en) 2013-01-22 2014-07-31 Novartis Ag Substituted purinone compounds
US9556180B2 (en) 2013-01-22 2017-01-31 Novartis Ag Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction
EP3412675A1 (en) 2013-05-27 2018-12-12 Novartis AG Imidazopyrrolidinone derivatives and their use in the treatment of disease
MX2015016421A (es) 2013-05-28 2016-03-03 Novartis Ag Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades.
AU2014272700B2 (en) 2013-05-28 2016-12-01 Novartis Ag Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
EA029269B1 (ru) 2013-11-21 2018-02-28 Новартис Аг Производные пирролопирролона и их применение для лечения заболеваний
WO2015108136A1 (ja) * 2014-01-17 2015-07-23 キッセイ薬品工業株式会社 α－置換グリシンアミド誘導体
JP6823587B2 (ja) 2015-04-13 2021-02-03 第一三共株式会社 Ｍｄｍ２阻害剤とｂｔｋ阻害剤との併用治療法
CN105693634B (zh) * 2016-03-17 2018-12-11 清华大学 化合物及其用途
CN115242726B (zh) * 2022-07-27 2024-03-01 阿里巴巴（中国）有限公司 队列的调度方法和装置及电子设备

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6092115A (en) * 1997-02-07 2000-07-18 Lucent Technologies Inc. Method for supporting per-connection queuing for feedback-controlled traffic
US6104700A (en) * 1997-08-29 2000-08-15 Extreme Networks Policy based quality of service
US6233245B1 (en) * 1997-12-24 2001-05-15 Nortel Networks Limited Method and apparatus for management of bandwidth in a data communication network
US6492553B1 (en) * 1998-01-29 2002-12-10 Aventis Pharamaceuticals Inc. Methods for preparing N-[(aliphatic or aromatic)carbonyl)]-2-aminoaetamide compounds and for cyclizing such compounds
US6515963B1 (en) * 1999-01-27 2003-02-04 Cisco Technology, Inc. Per-flow dynamic buffer management
US6680933B1 (en) * 1999-09-23 2004-01-20 Nortel Networks Limited Telecommunications switches and methods for their operation
WO2002084957A2 (en) * 2001-04-13 2002-10-24 Motorola, Inc., A Corporation Of The State Of Delaware Manipulating data streams in data stream processors

Also Published As

Publication number Publication date
EP1617807A2 (en) 2006-01-25
WO2004096134A3 (en) 2005-12-08
HRP20050919A2 (en) 2006-05-31
CA2523561A1 (en) 2004-11-11
CO5700770A2 (es) 2006-11-30
EP1617807A4 (en) 2007-02-21
NO20055568D0 (no) 2005-11-24
BRPI0409641A (pt) 2006-04-25
KR20060007035A (ko) 2006-01-23
AU2004233833A1 (en) 2004-11-11
US20040213264A1 (en) 2004-10-28
NO20055568L (no) 2006-01-20
MXPA05011411A (es) 2006-05-31
JP2007525457A (ja) 2007-09-06
CN1809362A (zh) 2006-07-26
WO2004096134A2 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
IS8074A (is) Setin 1,4- Díazepín og notkun theirra
NO20053974D0 (no) Tienopyrimidinforbindelser og anvendelse derav.
CY2018009I1 (el) Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων
CY2014041I1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
PL1628655T3 (pl) Kompozycje bakteriobójcze, sposoby i układy
DE602004029705D1 (de) 5,7-diaminopyrazoloä4,3-düpyrimidine mit pde-5-hemmender wirkung
NL1025404A1 (nl) Pyrazolo-triazine verbindingen en gebruik daarvan.
EP1557594A4 (en) OIL RING
EP1514544A4 (en) antiallergic
DE60326145D1 (de) Spielermittlungsverfahren
FR2843788B1 (fr) Entrainement
DK1562918T3 (da) Substituerede benzoxazinoner og anvendelser deraf
IS7829A (is) Nýjar 1,4-díazabísýklóalkan-afleiður, framleiðslaþeirra og notkun
DE60219211D1 (de) Sterilisator
DE502004002283D1 (de) Pasteurisierungsanlage
IS7980A (is) Díarýlmetýlídenpíperidínafleiður, framleiðsla þeirra og notkun
DK1487778T3 (da) Substituerede 4 aminocyclohexanoler
IS8489A (is) Umritunarstillar og aðferðir þeirra
IS7694A (is) Sterasamrunaefnasambönd, framleiðsla og notkun þeirra
IS7961A (is) Díarýlmetýlídenpíperidínafleiður, lyfjablöndur þeirra og notkun þeirra
DE50300456D1 (de) Drehsperre
DE60319388D1 (de) C6- UND C9-SUBSTITUIERTE CHROMENOÄ4,3-cÜISOXAZOLIN
DK1680134T3 (da) Sammensætninger og anvendelser deraf
NO20044405L (no) Neurotensinaktive 2,3-diaryl-pyrazolidin derivater
ATA14112002A (de) Schwenkschiebetür